Purpose: Transmission of infectious travel diseases is increasing, especially in travelers from developed to developing countries. Still, the incidence of many travel diseases is not known, because retrospective surveillance systems do not detect asymptomatic infections.
Methods: We took medical history and blood samples of 81 German travelers before and after travelling to South and Southeast Asia. IgG, IgM, and if possible IgA antibody titers were measured for Dengue virus (DENV), Chikungunya virus (CHIKV), Zika virus (ZIKV), Hepatitis E virus (HEV), and Camphylobacter jejuni (C.jejuni) using commercial ELISA kits. Additionally, we tested for Cytomegalovirus and Helicobacter pylori.
Results: No symptoms were reported. Still, we found one anti-ZIKV and two anti-DENV IgG seroconversions. For CHIKV, we found three individuals who were IgG-positive before travel and negative afterwards. We found five IgG seroconversions for C.jejuni and zero for HEV. We also found one IgG seroconversion for CMV, and zero for H.pylori. Calculated incidences were between zero and 6.5%.
Conclusion: Using serological analyses, we found a small but significant number of travel infections that would have gone unnoticed by retrospectively asking for symptoms alone. This suggests that the risk for these infections may be higher than previously estimated.